Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and levocetirizine

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with levocetirizine in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(levocetirizine)		Trials
(levocetirizine)		Recent Studies (post-2010) (levocetirizine)
9,156187552296110122

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badyal, DK; Johnson, M; Kwatra, G; Thomas, EA1

Trials

1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and levocetirizine

ArticleYear
Levocetirizine and rupatadine in chronic idiopathic urticaria.
    International journal of dermatology, 2015, Volume: 54, Issue:10

    Topics: Adolescent; Adult; Aged; Cetirizine; Child; Chronic Disease; Cyproheptadine; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Platelet Activating Factor; Quality of Life; Severity of Illness Index; Tumor Necrosis Factor-alpha; Urticaria; Young Adult

2015